Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
401 | 3531 | 34.9 | 74% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
14 | 4 | ORTHOPEDICS//DENTISTRY, ORAL SURGERY & MEDICINE//SPORT SCIENCES | 808941 |
32 | 3 | OSTEOPOROSIS//VITAMIN D//OSTEOPOROSIS INTERNATIONAL | 107093 |
433 | 2 | HYPERPARATHYROIDISM//PRIMARY HYPERPARATHYROIDISM//SECONDARY HYPERPARATHYROIDISM | 16350 |
401 | 1 | SECONDARY HYPERPARATHYROIDISM//PHOSPHATE BINDERS//HYPERPHOSPHATEMIA | 3531 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SECONDARY HYPERPARATHYROIDISM | authKW | 2147868 | 15% | 48% | 519 |
2 | PHOSPHATE BINDERS | authKW | 1684403 | 7% | 76% | 257 |
3 | HYPERPHOSPHATEMIA | authKW | 992009 | 7% | 44% | 260 |
4 | RENAL OSTEODYSTROPHY | authKW | 856565 | 7% | 42% | 236 |
5 | LANTHANUM CARBONATE | authKW | 819402 | 3% | 85% | 111 |
6 | SEVELAMER | authKW | 634343 | 3% | 77% | 95 |
7 | SEVELAMER HYDROCHLORIDE | authKW | 550504 | 2% | 86% | 74 |
8 | CINACALCET | authKW | 475708 | 3% | 47% | 118 |
9 | PARATHYROID HORMONE | authKW | 470283 | 12% | 13% | 420 |
10 | CALCIMIMETICS | authKW | 457611 | 3% | 45% | 118 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Urology & Nephrology | 172591 | 64% | 1% | 2259 |
2 | Transplantation | 11015 | 12% | 0% | 420 |
3 | Endocrinology & Metabolism | 2074 | 10% | 0% | 368 |
4 | Medical Laboratory Technology | 1547 | 4% | 0% | 131 |
5 | Hematology | 434 | 4% | 0% | 148 |
6 | Medicine, General & Internal | 303 | 6% | 0% | 212 |
7 | Medicine, Research & Experimental | 180 | 4% | 0% | 137 |
8 | Pediatrics | 105 | 3% | 0% | 104 |
9 | Pharmacology & Pharmacy | 94 | 6% | 0% | 206 |
10 | Engineering, Biomedical | 73 | 2% | 0% | 61 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NEPHROL BONE MINERAL METAB | 85912 | 1% | 31% | 32 |
2 | NEPHROL ENDOCRINOL METAB | 82589 | 1% | 33% | 29 |
3 | NEPHROL | 80832 | 22% | 1% | 771 |
4 | MINERVA CALCIUM BONE METAB | 55505 | 0% | 38% | 17 |
5 | NEPHROL BLOOD PURIFICAT MED | 44262 | 0% | 39% | 13 |
6 | CHROMALLOY AMER KIDNEY | 38904 | 0% | 75% | 6 |
7 | REINA SOFIA INVEST | 37128 | 1% | 23% | 19 |
8 | BLOOD PURIFICAT THER Y | 33207 | 0% | 27% | 14 |
9 | RENAL | 32235 | 4% | 3% | 137 |
10 | SERV NEFROL | 30391 | 3% | 4% | 92 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | THERAPEUTIC APHERESIS AND DIALYSIS | 95943 | 3% | 10% | 111 |
2 | NEPHROLOGY DIALYSIS TRANSPLANTATION | 87624 | 10% | 3% | 354 |
3 | KIDNEY INTERNATIONAL | 62119 | 9% | 2% | 323 |
4 | CLINICAL NEPHROLOGY | 45305 | 5% | 3% | 161 |
5 | NEFROLOGIA | 30598 | 3% | 4% | 95 |
6 | AMERICAN JOURNAL OF KIDNEY DISEASES | 24071 | 4% | 2% | 154 |
7 | NEPHRON CLINICAL PRACTICE | 21613 | 2% | 5% | 54 |
8 | JOURNAL OF RENAL NUTRITION | 20121 | 1% | 5% | 47 |
9 | ITALIAN JOURNAL OF MINERAL & ELECTROLYTE METABOLISM | 19735 | 0% | 14% | 16 |
10 | CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 17399 | 2% | 3% | 75 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SECONDARY HYPERPARATHYROIDISM | 2147868 | 15% | 48% | 519 | Search SECONDARY+HYPERPARATHYROIDISM | Search SECONDARY+HYPERPARATHYROIDISM |
2 | PHOSPHATE BINDERS | 1684403 | 7% | 76% | 257 | Search PHOSPHATE+BINDERS | Search PHOSPHATE+BINDERS |
3 | HYPERPHOSPHATEMIA | 992009 | 7% | 44% | 260 | Search HYPERPHOSPHATEMIA | Search HYPERPHOSPHATEMIA |
4 | RENAL OSTEODYSTROPHY | 856565 | 7% | 42% | 236 | Search RENAL+OSTEODYSTROPHY | Search RENAL+OSTEODYSTROPHY |
5 | LANTHANUM CARBONATE | 819402 | 3% | 85% | 111 | Search LANTHANUM+CARBONATE | Search LANTHANUM+CARBONATE |
6 | SEVELAMER | 634343 | 3% | 77% | 95 | Search SEVELAMER | Search SEVELAMER |
7 | SEVELAMER HYDROCHLORIDE | 550504 | 2% | 86% | 74 | Search SEVELAMER+HYDROCHLORIDE | Search SEVELAMER+HYDROCHLORIDE |
8 | CINACALCET | 475708 | 3% | 47% | 118 | Search CINACALCET | Search CINACALCET |
9 | PARATHYROID HORMONE | 470283 | 12% | 13% | 420 | Search PARATHYROID+HORMONE | Search PARATHYROID+HORMONE |
10 | CALCIMIMETICS | 457611 | 3% | 45% | 118 | Search CALCIMIMETICS | Search CALCIMIMETICS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BRANDI, L , (2008) 1 ALPHA(OH)D-3 ONE-ALPHA-HYDROXY-CHOLECALCIFEROL - AN ACTIVE VITAMIN D ANALOG CLINICAL STUDIES ON PROPHYLAXIS AND TREATMENT OF CEDONDARY HYPERPARATHYROIDISM IN UREMIC PATIENTS ON CHRONIC DIALYSIS.DANISH MEDICAL BULLETIN. VOL. 55. ISSUE 4. P. 186 -210 | 164 | 64% | 14 |
2 | PERRY, CM , PLOSKER, GL , (2014) SEVELAMER CARBONATE: A REVIEW IN HYPERPHOSPHATAEMIA IN ADULTS WITH CHRONIC KIDNEY DISEASE.DRUGS. VOL. 74. ISSUE 7. P. 771 -792 | 84 | 84% | 4 |
3 | FUKAGAWA, M , YOKOYAMA, K , KOIWA, F , TANIGUCHI, M , SHOJI, T , KAZAMA, JJ , KOMABA, H , ANDO, R , KAKUTA, T , FUJII, H , ET AL (2013) CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER.THERAPEUTIC APHERESIS AND DIALYSIS. VOL. 17. ISSUE 3. P. 247 -288 | 143 | 43% | 31 |
4 | TONELLI, M , PANNU, N , MANNS, B , (2010) DRUG THERAPY: ORAL PHOSPHATE BINDERS IN PATIENTS WITH KIDNEY FAILURE..NEW ENGLAND JOURNAL OF MEDICINE. VOL. 362. ISSUE 14. P. 1312 -1324 | 71 | 80% | 141 |
5 | NAVANEETHAN, SD , PALMER, SC , VECCHIO, M , CRAIG, JC , ELDER, GJ , STRIPPOLI, GFM , (2011) PHOSPHATE BINDERS FOR PREVENTING AND TREATING BONE DISEASE IN CHRONIC KIDNEY DISEASE PATIENTS.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 2. P. - | 74 | 87% | 13 |
6 | FLOEGE, J , (2016) PHOSPHATE BINDERS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW OF RECENT DATA.JOURNAL OF NEPHROLOGY. VOL. 29. ISSUE 3. P. 329 -340 | 74 | 69% | 2 |
7 | RODRIGUEZ, M , NEMETH, E , MARTIN, D , (2005) THE CALCIUM-SENSING RECEPTOR: A KEY FACTOR IN THE PATHOGENESIS OF SECONDARY HYPERPARATHYROIDISM.AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY. VOL. 288. ISSUE 2. P. F253 -F264 | 91 | 73% | 92 |
8 | COZZOLINO, M , BOVER, J , URENA, P , RUIZ-GARCIA, C , DASILVA, L , LESCANO, P , DEL CARPIO, J , BALLARIN, J , (2016) CLINICAL AND PRACTICAL USE OF CALCIMIMETICS IN DIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM.CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. VOL. 11. ISSUE 1. P. 161 -174 | 63 | 80% | 2 |
9 | SALAM, SN , KHWAJA, A , WILKIE, ME , (2016) PHARMACOLOGICAL MANAGEMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS WITH CHRONIC KIDNEY DISEASE.DRUGS. VOL. 76. ISSUE 8. P. 841 -852 | 80 | 66% | 1 |
10 | NAVANEETHAN, SD , PALMER, SC , CRAIG, JC , ELDER, GJ , STRIPPOLI, GFM , (2009) BENEFITS AND HARMS OF PHOSPHATE BINDERS IN CKD: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS.AMERICAN JOURNAL OF KIDNEY DISEASES. VOL. 54. ISSUE 4. P. 619-637 | 59 | 92% | 82 |
Classes with closest relation at Level 1 |